Abacus Medicine is a leading European pharmaceutical company specializing in parallel distribution (also known as parallel import) of original prescription medicines. Founded in 2004, the company sources medicines from EU/EEA countries where they are cheaper and sells them in other European countries where prices are higher, thereby contributing to healthcare cost savings and increased patient access. Abacus Medicine is committed to quality, reliability, and operates with a strong entrepreneurial spirit across its markets.
The Copenhagen headquarters serves as the central command for Abacus Medicine's European operations, overseeing strategic planning, finance, global sourcing, quality assurance, regulatory affairs, and sales coordination across its various markets.
The headquarters is situated in a modern office complex in the Kalvebod Brygge waterfront area, known for its contemporary architecture and dynamic business environment, likely offering views of Copenhagen's harbour.
Abacus Medicine fosters an entrepreneurial, ambitious, and results-driven work culture. Collaboration, dedication, and a fast-paced environment are characteristic, reflecting its growth-oriented nature in the competitive pharmaceutical sector.
The Copenhagen HQ is crucial for managing and expanding Abacus Medicine's extensive parallel distribution network throughout Europe, ensuring efficient operations and market responsiveness.
Abacus Medicine has a significant presence across Europe, with active operations in over 12 countries including Germany, the United Kingdom, the Netherlands, Austria, Sweden, Finland, France, Spain, and Italy. Its global functions primarily support its core business of parallel distribution of pharmaceuticals within the European Economic Area. This includes international sourcing of medicines, pan-European sales and marketing, complex logistics and supply chain management, robust quality assurance processes, and navigating diverse regulatory landscapes across multiple European nations.
Kalvebod Brygge 39-41
Copenhagen V
Denmark
Address: Abacus Medicine GmbH, Lilienthalallee 40, MOC C218, 80939 Munich, Germany
Serves as a key hub for Abacus Medicine's activities in Germany, ensuring localized market access and customer support for parallel distributed medicines.
Address: Pluripharm Group B.V. (an Abacus Medicine subsidiary), Koolhovenlaan 1, 1119 NB Schiphol-Rijk, Netherlands
Strengthens Abacus Medicine's presence in the Benelux region, providing comprehensive wholesale and distribution services in the Dutch pharmaceutical market.
Address: Abacus Medicine Hungary Kft., Váci út 76. Capital Square II. torony 3.emelet, 1133 Budapest, Hungary
Serves as an operational hub for Central and Eastern Europe, leveraging local market expertise for sourcing and sales of parallel imported pharmaceuticals.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Abacus Medicine' leadership includes:
Abacus Medicine has been backed by several prominent investors over the years, including:
In the last 12 months (from mid-2023 to mid-2024), Abacus Medicine notably strengthened its executive team with the appointment of a new Chief Financial Officer.
Discover the tools Abacus Medicine uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Abacus Medicine's most common email format appears to be [first_initial][last_name]@[company_domain] (e.g., jsmith@abacusmedicine.com). Variations might exist, but this is a frequently observed pattern for the company.
flast@abacusmedicine.com
Format
fwagner@abacusmedicine.com
Example
75%
Success rate
GlobeNewswire / Abacus Medicine Investor Relations • May 15, 2024
Abacus Medicine A/S reported strong financial results for the first quarter of 2024, with organic revenue growth of 16% and an EBITDA increase. The company highlighted robust performance across its segments and reiterated its financial guidance for the full year....more
GlobeNewswire / Abacus Medicine Investor Relations • February 28, 2024
Abacus Medicine released its Annual Report for 2023, showcasing record-high revenue and improved normalised earnings. The report detailed the company's strategic progress and market expansion efforts throughout the year....more
Abacus Medicine Press Release • September 1, 2023
Abacus Medicine announced that Henrik Ljungström had officially started his role as the new Chief Financial Officer (CFO) of the company, bringing significant experience from previous financial leadership positions....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Abacus Medicine, are just a search away.